165 related articles for article (PubMed ID: 1351849)
21. Alpha 2C-adrenoceptors mediate contractile responses to noradrenaline in the human saphenous vein.
Gavin KT; Colgan MP; Moore D; Shanik G; Docherty JR
Naunyn Schmiedebergs Arch Pharmacol; 1997 Mar; 355(3):406-11. PubMed ID: 9089673
[TBL] [Abstract][Full Text] [Related]
22. Alpha 2-adrenoceptor blocking profile of SK&F 104078: further evidence for receptor subtypes.
Akers I; Coates J; Drew GM; Sullivan AT
Br J Pharmacol; 1991 Apr; 102(4):943-9. PubMed ID: 1677300
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms underlying the differential sensitivity to alpha 1-adrenoceptor activation in the bisected rat vas deferens.
Sallés J; Badia A
Br J Pharmacol; 1991 Feb; 102(2):439-45. PubMed ID: 1673073
[TBL] [Abstract][Full Text] [Related]
24. Additional evidence for functional subclassification of alpha-2 adrenoceptors based on a new selective antagonist, SK&F 104856.
Hieble JP; Sulpizio AC; Edwards R; Chapman H; Young P; Roberts SP; Blackburn TP; Wood MD; Shah DH; Demarinis RM
J Pharmacol Exp Ther; 1991 Nov; 259(2):643-52. PubMed ID: 1682482
[TBL] [Abstract][Full Text] [Related]
25. Investigation of postjunctional alpha1- and alpha2-adrenoceptor subtypes in vas deferens from wild-type and alpha(2A/D)-adrenoceptor knockout mice.
Cleary L; Vandeputte C; Docherty JR
Br J Pharmacol; 2003 Mar; 138(6):1069-76. PubMed ID: 12684262
[TBL] [Abstract][Full Text] [Related]
26. [3H]-RS-15385-197, a selective and high affinity radioligand for alpha 2-adrenoceptors: implications for receptor classification.
MacKinnon AC; Kilpatrick AT; Kenny BA; Spedding M; Brown CM
Br J Pharmacol; 1992 Aug; 106(4):1011-8. PubMed ID: 1327384
[TBL] [Abstract][Full Text] [Related]
27. Actions of 8-hydroxy-2-(N-dipropylamino) tetralin (8-OH-DPAT) at alpha 2-adrenoceptors.
Borton M; Connaughton S; Docherty JR
J Auton Pharmacol; 1991 Aug; 11(4):247-53. PubMed ID: 1658007
[TBL] [Abstract][Full Text] [Related]
28. Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems.
Doxey JC; Roach AG; Strachan DA; Virdee NK
Br J Pharmacol; 1984 Nov; 83(3):713-22. PubMed ID: 6150740
[TBL] [Abstract][Full Text] [Related]
29. Modulation of alpha 1-adrenoceptors and functional consequences in the bisected rat vas deferens following chronic inhibition of neuronal noradrenaline uptake.
Sallés J; Badia A
Br J Pharmacol; 1993 Mar; 108(3):678-83. PubMed ID: 8096783
[TBL] [Abstract][Full Text] [Related]
30. Characterization of alpha 1-adrenoceptor subtypes in tension response of human prostate to electrical field stimulation.
Guh JH; Chueh SC; Ko FN; Teng CM
Br J Pharmacol; 1995 May; 115(1):142-6. PubMed ID: 7647968
[TBL] [Abstract][Full Text] [Related]
31. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
[TBL] [Abstract][Full Text] [Related]
32. Effects of desipramine on stimulation-induced contractions of the vas deferens of rats pretreated either chronically with desipramine or acutely with idazoxan.
Doxey JC; Roach AG; Samuel J
Clin Sci (Lond); 1985; 68 Suppl 10():155s-159s. PubMed ID: 2857613
[TBL] [Abstract][Full Text] [Related]
33. Activation of alpha 1-adrenoceptors increases [3H]inositol metabolism in rat vas deferens and caudal artery.
Fox AW; Abel PW; Minneman KP
Eur J Pharmacol; 1985 Oct; 116(1-2):145-52. PubMed ID: 2865157
[TBL] [Abstract][Full Text] [Related]
34. Sympathectomy reveals alpha 1A- and alpha 1D-adrenoceptor components to contractions to noradrenaline in rat vas deferens.
Cleary L; Slattery J; Bexis S; Docherty JR
Br J Pharmacol; 2004 Nov; 143(6):745-52. PubMed ID: 15451776
[TBL] [Abstract][Full Text] [Related]
35. Differential antagonism by conotoxin rho-TIA of contractions mediated by distinct alpha1-adrenoceptor subtypes in rat vas deferens, spleen and aorta.
Lima V; Mueller A; Kamikihara SY; Raymundi V; Alewood D; Lewis RJ; Chen Z; Minneman KP; Pupo AS
Eur J Pharmacol; 2005 Jan; 508(1-3):183-92. PubMed ID: 15680270
[TBL] [Abstract][Full Text] [Related]
36. The alpha (1D)-adrenoceptor antagonist BMY 7378 is also an alpha (2C)-adrenoceptor antagonist.
Cleary L; Murad K; Bexis S; Docherty JR
Auton Autacoid Pharmacol; 2005 Oct; 25(4):135-41. PubMed ID: 16176444
[TBL] [Abstract][Full Text] [Related]
37. An investigation of presynaptic alpha-adrenoceptor subtypes in the pithed rat heart and in the rat isolated vas deferens.
Docherty JR
Br J Pharmacol; 1984 May; 82(1):15-23. PubMed ID: 6145465
[TBL] [Abstract][Full Text] [Related]
38. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
Hanft G; Gross G
Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345
[TBL] [Abstract][Full Text] [Related]
39. Investigation of the subtype of alpha 2-adrenoceptor mediating pressor responses in the pithed rat.
Gavin K; Docherty JR
Eur J Pharmacol; 1996 Dec; 318(1):81-7. PubMed ID: 9007516
[TBL] [Abstract][Full Text] [Related]
40. Comparison of potency of alpha 2-adrenoceptor antagonists in vitro: evidence for heterogeneity of alpha 2-adrenoceptors.
Alabaster VA; Keir RF; Peters CJ
Br J Pharmacol; 1986 Jul; 88(3):607-14. PubMed ID: 2874857
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
